Department of Endocrinology, Thyroid Center of New Hampshire, Nashua, New Hampshire, USA.
Thyroid. 2023 Aug;33(8):894-902. doi: 10.1089/thy.2022.0346.
From low-resolution images in the 1960s to current high-resolution technology, ultrasound has proven to be the initial imaging modality of choice for thyroid application. Point-of-care ultrasound has brought the technology to the thyroid specialist. Combined with physical examination, it provides real-time information regarding goiter, thyroid nodules, and thyroid cancer. Ultrasound-guided fine-needle aspiration biopsy has become the accepted norm, with biopsies rarely performed using palpation alone. Advantages of ultrasound-guided biopsy include precise placement of the needle within the nodule, selective sampling of areas with suspicious features, and accurate direction of the biopsy needle to actively growing viable cells in the periphery of the nodule. Education of endocrinologists in thyroid ultrasound began in the late 1990s and by 2016 more than 6000 clinicians had completed an ultrasound course. Concurrent with this rapid expansion of use of thyroid ultrasound was a rise in the diagnosis of small papillary carcinomas, which might have otherwise remained indolent and undetected. The 2009 American Thyroid Association Guidelines for the Management of Thyroid Nodules and Thyroid Cancer recommended biopsy for all solid hypoechoic nodules measuring larger than 1 cm. Attempting to decrease the frequency of biopsies of low-risk nodules, subsequent guidelines have focused on identifying and selectively biopsying those thyroid nodules at higher risk of clinically significant carcinoma based on ultrasound appearance. A major role for thyroid ultrasound has been in both preoperative staging and mapping to help determine the extent of surgery, as well as postoperative monitoring for locoregional soft tissue or lymph node metastases. With the recognition that the increase in papillary carcinoma was predominantly a result of early diagnosis of small often indolent cancers, active surveillance has become a promising management strategy for papillary thyroid microcarcinomas. Thyroid ultrasound is essential to active surveillance of thyroid cancer. Easy access to high-quality ultrasound studies is a requirement for a successful active surveillance program. Thyroid ultrasound has been used to facilitate interventional procedures, including treatment of thyroid nodules, treatment of recurrent thyroid cancer, and therapy of papillary thyroid microcarcinoma.
从 20 世纪 60 年代的低分辨率图像到当前的高分辨率技术,超声已被证明是甲状腺应用的首选初始成像方式。即时超声技术已将该技术带到甲状腺专家手中。结合体检,它可以提供有关甲状腺肿、甲状腺结节和甲状腺癌的实时信息。超声引导下细针抽吸活检已成为公认的标准,很少单独使用触诊进行活检。超声引导活检的优点包括将针精确地置于结节内,选择性地对具有可疑特征的区域进行采样,以及准确地将活检针引导至结节周围活跃的有活力的细胞。甲状腺超声的内分泌学家教育始于 20 世纪 90 年代末,到 2016 年,已有超过 6000 名临床医生完成了超声课程。与此同时,甲状腺超声的使用迅速扩大,小的乳头状癌的诊断也有所增加,否则这些癌可能仍处于惰性状态而未被发现。2009 年美国甲状腺协会(ATA)发布的《甲状腺结节和甲状腺癌管理指南》建议对所有直径大于 1cm 的实性低回声结节进行活检。为了减少低危结节活检的频率,后续指南侧重于根据超声表现识别和选择性地对那些具有更高临床显著癌风险的甲状腺结节进行活检。甲状腺超声的一个主要作用是在术前分期和定位,以帮助确定手术范围,以及在术后监测局部软组织或淋巴结转移。随着认识到乳头状癌的增加主要是由于早期诊断小的、通常惰性的癌症,主动监测已成为治疗甲状腺微小乳头状癌的一种有前途的管理策略。甲状腺超声对于甲状腺癌的主动监测至关重要。方便获得高质量的超声研究是成功实施主动监测计划的必要条件。甲状腺超声已用于辅助介入性操作,包括甲状腺结节的治疗、复发性甲状腺癌的治疗以及甲状腺微小乳头状癌的治疗。